Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

The lack of clinical trials may be holding back AI adoption in healthcare

The healthcare industry has a lot of hope for machine learning solutions across patient care. However, there are many barriers to widespread adoption keeping machine learning from being implemented into clinical practice.

Thumbnail

White House works with health tech companies to address social determinants of health

A number of major health technology companies have partnered with the White House in an effort to standardize the sharing of patient data on social determinants of health.

Medicare money payment physician

Medicare premiums will drop in 2023

Medicare Part A and B premiums will drop in 2023, marking the first decrease in a decade.

AMA analysis of Medicare Trustee data shows Medicare updates compared to inflation 2001-2021.

More than 100 medical societies push Congress to end destructive cycle of annual Medicare cuts

More than 120 medical societies have joined the AMA in a letter urging congressional leaders to enact long-term solutions to the systemic problems in the Medicare physician payment system and to address cuts that are going into effect in 2023.

Medicare money payment physician

The fight continues: Cardiologists turn up heat on Congress to stop Medicare payment cuts

Dozens of medical societies have signed a new letter urging Congress to stop upcoming Medicare payment cuts. “The Medicare payment system remains on an unsustainable path threatening beneficiaries’ access to physicians," they wrote. 

President Biden declares COVID-19 pandemic is ‘over’

President Joe Biden said the COVID-19 “pandemic is over” during an interview with 60 Minutes.

Thumbnail

District Court ruling in Texas calls ACA preventive care requirement ‘unconstitutional’

The federally-appointed judge expressed concerns that volunteer experts on the U.S. Preventive Services Task Force have the power to make binding recommendations.

Monkeypox update: FDA focuses on testing as cases continue to rise

The new guidance offers a validation template that can assist test developers in submitting an Emergency Use Authorization (EUA) request. 

Displaying 537 - 544 of 2772

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup